Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ASST | DNOW |
|---|---|---|
| Price | $30.26 | $15.90 |
| Change today | ▲ 0.77% | ▲ 0.89% |
| Market cap | $2.87B | $2.87B |
| Return, 3 months | +138.3% | +25.6% |
| Return, year to date | +105.0% | +20.0% |
| Return, 1 year | -40.2% | -0.1% |
| P/E (TTM) | -30.3 | -11.1 |
| P/B | 4.4 | 1.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +27.2% | +16.4% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 71 | 53 |
| 30-day volatility | 65.7% | 28.6% |
| Max drawdown, 1 year | -89.3% | -34.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
